International Cancer Research Group, United Arab Emirates
2 clinical trials · Sponsor
◉ Watch International Cancer Research Group, United Arab Emirates
| Record | Firm | Date |
|---|---|---|
| Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. (NCT05190094) | International Cancer Research Group, United Arab Emirates | 2022-12-20 |
| Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant (NCT03447132) | International Cancer Research Group, United Arab Emirates | 2017-12-20 |
Track International Cancer Research Group, United Arab Emirates automatically
Every clearance here is in the API, with alerts when new ones post.